Literature DB >> 16462713

Diabetes mellitus and impaired glucose tolerance in thalassaemia major: incidence, prevalence, risk factors and survival in patients followed in the Ferrara Center.

Maria Rita Gamberini1, Monica Fortini, Vincenzo De Sanctis, Giuseppe Gilli, Maria Rosaria Testa.   

Abstract

Two hundred and seventy-three patients with thalassaemia major (TM) were followed in the Ferrara Thalassaemia Centre over a thirty-year period. Forty-two patients had insulin dependent diabetes mellitus (IDDM). The first case was diagnosed in 1973. The incidence of IDDM peaked in 1986 (3.9%), and it was 0.7% at the time of the study (March 1998). The prevalence of IDDM increased progressively over time, reaching 14.2% in 1998. Mean age at diagnosis of IDDM was 18.2 -/+ 3.6 years and this also rose significantly during the study period (p<0.01). Hypogonadism was present in 91% of patients with IDDM, hypothyroidism in 68%, hypoparathyroidism in 21%, and cardiopathy in 69%, all significantly more prevalent than in patients without IDDM. These complications appeared with the same frequency before and after the diagnosis of IDDM. Survival of patients with and without IDDM was similar and no difference in the primary cause of death was found between the two groups. Main risk factors associated with IDDM were poor compliance with desferioxamine (DFO) treatment (p<0.05%), advanced age at the start of intensive chelation therapy (p<0.001), liver cirrhosis or severe fibrosis (p<0.0001, odds ratio 9.5, CI 95% 2.8-32.6). Prevalence of impaired glucose tolerance (IGT) was highest in 1981, 1984, and 1985 when the incidence of IDDM was increasing; in 1995 the prevalence of IGT in patients aged 16-20 years was lower in comparison with that observed in 1975 (17% vs. 59%, p<0.01). Risk factors associated with IGT were: male sex (p<0.05), poor compliance with DFO therapy (p<0.05) and liver iron concentration 4 times above the normal value. In conclusion, our longitudinal study confirms that the incidence of IDDM and prevalence of IGT have been decreasing over the course of the last decade, appearing at a more advanced age, although some differences have not reached statistical significance. Iron overload and liver disease were the main associated risk factors, while positive family history for diabetes did not influence glucose metabolism in our patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16462713

Source DB:  PubMed          Journal:  Pediatr Endocrinol Rev        ISSN: 1565-4753


  10 in total

Review 1.  Growth and endocrine function in thalassemia major in childhood and adolescence.

Authors:  M Delvecchio; L Cavallo
Journal:  J Endocrinol Invest       Date:  2010-01       Impact factor: 4.256

2.  Diabetes Mellitus in Thalassaemia Major Patients: A Report from the Southeast of Iran.

Authors:  Ali Bazi; Javad Sharifi-Rad; Daryoush Rostami; Omolbanin Sargazi-Aval; Amin Safa
Journal:  J Clin Diagn Res       Date:  2017-05-01

Review 3.  Iron Chelators in Treatment of Iron Overload.

Authors:  Sarina Entezari; Seyedeh Mona Haghi; Narges Norouzkhani; Barsa Sahebnazar; Fatemeh Vosoughian; Diba Akbarzadeh; Muhammad Islampanah; Navid Naghsh; Mohammad Abbasalizadeh; Niloofar Deravi
Journal:  J Toxicol       Date:  2022-05-05

4.  Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America.

Authors:  Maria G Vogiatzi; Eric A Macklin; Felicia L Trachtenberg; Ellen B Fung; Angela M Cheung; Elliott Vichinsky; Nancy Olivieri; Melody Kirby; Janet L Kwiatkowski; Melody Cunningham; Ingrid A Holm; Martin Fleisher; Robert W Grady; Charles M Peterson; Patricia J Giardina
Journal:  Br J Haematol       Date:  2009-07-13       Impact factor: 6.998

Review 5.  Endocrine and bone complications in β-thalassemia intermedia: current understanding and treatment.

Authors:  Adlette Inati; MohammadHassan A Noureldine; Anthony Mansour; Hussein A Abbas
Journal:  Biomed Res Int       Date:  2015-03-05       Impact factor: 3.411

6.  Secondary haemochromatosis in a patient with thalassemia intermedia.

Authors:  Ionela Rotaru; Amelia Gaman; G Gaman
Journal:  Curr Health Sci J       Date:  2013-12-29

7.  The ICET-A Recommendations for the Diagnosis and Management of Disturbances of Glucose Homeostasis in Thalassemia Major Patients.

Authors:  Vincenzo De Sanctis; Ashraf T Soliman; Heba Elsedfy; Saif Al Yaarubi; Nicos Skordis; Doaa Khater; Mohamed El Kholy; Iva Stoeva; Bernadette Fiscina; Michael Angastiniotis; Shahina Daar; Christos Kattamis
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-10-28       Impact factor: 2.576

Review 8.  Iron Reshapes the Gut Microbiome and Host Metabolism.

Authors:  Amy Botta; Nicole G Barra; Nhat Hung Lam; Samantha Chow; Kostas Pantopoulos; Jonathan D Schertzer; Gary Sweeney
Journal:  J Lipid Atheroscler       Date:  2021-03-10

9.  Glucose homeostasis in Egyptian children and adolescents with β-Thalassemia major: Relationship to oxidative stress.

Authors:  Kotb Abbass Metwalley; Abdel-Rahman Abdel-Hamed El-Saied
Journal:  Indian J Endocrinol Metab       Date:  2014-05

10.  Growth and Endocrine Function in Tunisian Thalassemia Major Patients.

Authors:  Naouel Guirat Dhouib; Monia Ben Khaled; Monia Ouederni; Habib Besbes; Ridha Kouki; Fethi Mellouli; Mohamed Bejaoui
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-05-01       Impact factor: 2.576

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.